Company | Otis Worldwide Corporation |
Ticker | NYSE: OTIS |
Upcoming Earnings Date | July 22, 2026 — 8:30 AM ET (Q2 2026) |
Preparation Date | July 21, 2026 |
Last Earnings | Q1 2026 — April 22, 2026 |
Sector ETF Benchmark | XLI (Industrials Select Sector SPDR) |
Key Takeaway: The setup into Q2 2026 is a low bar with meaningful upside optionality — consensus already prices in a ~3–5% EPS decline year-over-year (guided by management), making the key swing factor whether service margin recovers sequentially toward the guided ~24% level and whether Middle East headwinds ease as assumed.
Heading into Q2 2026, the bar for OTIS is deliberately low: management guided adjusted EPS down 3–5% year-over-year at a similar magnitude to Q1’s decline, and consensus at ~$1.03 reflects that guidance almost exactly, leaving little room for a negative surprise but meaningful upside if execution improves. Management’s posture on the Q1 call was cautiously constructive — they reaffirmed full-year guidance, provided a detailed quarterly recovery path for service margins (Q2 ~24%, stabilize in Q3, expand year-over-year in Q4), and expressed confidence that the H1 headwinds are transitory and recoverable. Estimate revisions since the Q1 print have been modest and largely in line with guidance, with the 2Q FY2026 EPS consensus moving from $1.01 (as of April 27) to $1.03 currently, suggesting the Street has largely digested the guided step-down without further deterioration. The stock has underperformed materially since Q1 earnings — down ~7.6% vs. XLI +4.5% and SPY +5.2% — trading at a low-20s forward P/E that sits below its historical average and well below the peer group, implying the market has already priced in significant execution risk and leaving the stock with asymmetric upside if H2 recovery materializes. The single biggest wildcard is the Middle East conflict trajectory: management’s Q2 guidance explicitly assumed the conflict ends in Q2, and if it persists, the company flagged a $5–10M per quarter profit headwind from project delays, logistics disruptions, and cost inflation — a risk that peers including Trane Technologies, Carrier, Honeywell, and Emerson all flagged as a live headwind in their own Q1/Q2 prints.
Key Takeaway: Consensus reflects a low bar — EPS guided down 3–5% YoY and already embedded in estimates. Service margin is the bigger swing factor: a sequential recovery from Q1’s 23.0% toward the guided ~24% would be the primary positive catalyst, while any further deterioration would be the key downside risk.
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | Guidance | Consensus vs. Guidance |
Net Sales ($B) | $3.566B | $3.595B | $3.742B | +4.1% | $15.1–15.3B (FY) | In line with FY run-rate |
Service Sales ($B) | $2.417B | $2.319B | $2.482B | +7.0% | Mid-to-high single-digit organic growth | In line |
New Equipment Sales ($B) | $1.149B | $1.276B | $1.262B | -1.1% | Down low single digits to flat (organic) | In line |
Adj. EPS (Diluted, Operating) | $0.89 | $1.05 | $1.03 | -1.9% | Down 3–5% YoY (Q2 specific) | ~+1% above guidance midpoint |
Service Operating Margin (%) | 23.0% | 24.9% | 24.3% | -60 bps | ~24% (Q2 specific guidance) | +30 bps above guidance |
New Equipment Operating Margin (%) | 3.3% | 5.3% | 3.7% | -160 bps | ~3% for balance of year | +70 bps above guidance |
Service Organic Growth (%) | 5.0% | 4.0% | 5.9% | +190 bps | Mid-to-high single digits | In line |
New Equipment Organic Growth (%) | -5.0% | -11.0% | -1.9% | +910 bps | Down low single digits to flat | In line |
Free Cash Flow ($B) | $0.380B | $0.179B | $0.370B | +107% | $1.60–1.65B (FY) | In line with FY run-rate |
Source: Visible Alpha Consensus and Actuals Data. All consensus figures as of July 21, 2026. Q2 2026 guidance per Q1 2026 earnings call (April 22, 2026).
Quarter | KPI | Reported | Consensus | Surprise % | Result |
Q1 2026 | Adj. EPS | $0.89 | $0.907 | -1.9% | Miss |
Q1 2026 | Service Organic Growth | 5.0% | 6.0% | -100 bps | Miss |
Q4 2025 | Adj. EPS | $1.03 | $1.032 | -0.2% | In Line |
Q4 2025 | Service Organic Growth | 5.0% | 6.3% | -130 bps | Miss |
Q3 2025 | Adj. EPS | $1.05 | $1.008 | +4.2% | Beat |
Q3 2025 | Service Organic Growth | 6.0% | 6.1% | -10 bps | In Line |
Q2 2025 | Adj. EPS | $1.05 | $1.021 | +2.8% | Beat |
Q2 2025 | Service Organic Growth | 4.0% | 6.3% | -230 bps | Miss |
Q1 2025 | Adj. EPS | $0.92 | $0.905 | +1.7% | Beat |
Q1 2025 | Service Organic Growth | 4.0% | 5.9% | -190 bps | Miss |
Q4 2024 | Adj. EPS | $0.93 | $0.959 | -3.0% | Miss |
Q4 2024 | Service Organic Growth | 7.8% | 7.5% | +30 bps | Beat |
Q3 2024 | Adj. EPS | $0.96 | $0.967 | -0.7% | In Line |
Q3 2024 | Service Organic Growth | 7.7% | 6.6% | +110 bps | Beat |
Q2 2024 | Adj. EPS | $1.06 | $1.025 | +3.4% | Beat |
Q2 2024 | Service Organic Growth | 5.1% | 6.5% | -140 bps | Miss |
Pattern: OTIS has a consistent track record of beating EPS consensus (5 of 8 quarters) but chronically missing service organic growth estimates (6 of 8 quarters), reflecting the Street’s persistent tendency to over-estimate service revenue acceleration — a pattern that makes the current consensus service organic growth estimate of ~5.9% a meaningful risk heading into Q2.
Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Guidance has not changed since the Q1 2026 earnings call — no post-earnings 8-K, conference, or investor day has revised the numbers. Tone is cautiously constructive: management reaffirmed the full-year framework and provided a detailed quarterly recovery path for service margins, but the high end of EPS guidance was cut at Q1 and the bar for H2 execution remains high.
Metric | Initial Guidance (Q1 2026 Earnings Call — Apr 22, 2026) | Revised Guidance | Current Consensus | Note |
FY 2026 Net Sales | $15.1–15.3B | — | $15.12B | Unchanged; low end raised from prior guide; consensus at low end of range |
FY 2026 Organic Sales Growth | Up low to mid-single digits | — | ~6.1% | Unchanged; consensus at upper end of guidance range |
FY 2026 Service Organic Growth | Mid-to-high single digits | — | ~6.1% | Unchanged; 1–2 pts acceleration vs. 2025 |
FY 2026 New Equipment Organic Growth | Down low single digits to flat | — | ~-1.3% | Unchanged; consensus in line with guidance |
FY 2026 Adj. EPS | $4.20–$4.24 (narrowed; high end cut from prior $4.25+) | — | $4.20 | ↓ High end cut at Q1 earnings; consensus at low end of range; mid-single-digit growth vs. 2025 |
FY 2026 Adj. Free Cash Flow | $1.60–$1.65B | — | $1.61B | Unchanged; high end tightened slightly at Q1; consensus in line |
Q2 2026 Adj. EPS | Down 3–5% YoY (vs. $1.05 in Q2 2025) | — | $1.03 | Consensus at ~$1.00–1.02 implied range; slightly above midpoint |
Q2 2026 Service Margin | ~24% (sequential improvement from Q1’s 23.0%) | — | 24.3% | Consensus slightly above guidance; key swing factor for the print |
Middle East Conflict Assumption | Assumes conflict ends in Q2; $5–10M/qtr headwind if it continues | — | N/A | Key risk: if conflict persists into Q3, guidance may need revision |
FY 2026 Adj. Operating Profit | ~$2.5B; up $20–60M at constant currency | — | N/A (FY) | Unchanged; tariffs now a modest tailwind (+$10M vs. original guidance) |
Key Takeaway: Estimates have been largely stable since the Q1 print, with Q2 EPS ticking up modestly from $1.01 to $1.03 — suggesting the Street has absorbed the guided step-down without further deterioration. FY 2026 EPS consensus at $4.20 sits at the low end of guidance, implying the market is not yet giving management credit for the H2 recovery story; any evidence of service margin inflection in Q2 could be a meaningful positive catalyst for estimate revisions.
KPI (Period) | Estimate (Apr 27, 2026 — 5 Days Post Q1 Print) | Current Consensus (Jul 21, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Adj. EPS — Q2 2026 | $1.011 | $1.033 | +2.2% | Down 3–5% YoY (~$1.00–1.02) | Unchanged | — | ~+1% above midpoint |
Adj. EPS — FY 2026 | $4.172 | $4.195 | +0.6% | $4.20–$4.24 | Unchanged | — | At low end of range |
Net Sales — Q2 2026 | $3.744B | $3.742B | -0.1% | $15.1–15.3B (FY) | Unchanged | — | In line with FY run-rate |
Net Sales — FY 2026 | $15.142B | $15.122B | -0.1% | $15.1–15.3B | Unchanged | — | At low end of range |
Service Sales — Q2 2026 | $2.491B | $2.482B | -0.4% | Mid-to-high single-digit organic | Unchanged | — | In line |
Service Margin — Q2 2026 | 24.0% | 24.3% | +30 bps | ~24% | Unchanged | — | +30 bps above guidance |
Service Organic Growth — Q2 2026 | 5.9% | 5.9% | Flat | Mid-to-high single digits | Unchanged | — | In line |
New Equipment Organic Growth — Q2 2026 | -2.8% | -1.9% | +90 bps | Down low single digits to flat | Unchanged | — | In line |
Source: Visible Alpha Consensus and Actuals Data. Post-Q1 baseline as of April 27, 2026 (5 trading days after April 22, 2026 earnings). Current consensus as of July 21, 2026.
Estimates have been remarkably stable since the Q1 print, with EPS ticking up modestly (+2.2% for Q2, +0.6% for FY) as the Street absorbed the guided step-down without further cuts. The FY 2026 EPS consensus at $4.20 sits at the low end of the $4.20–$4.24 guidance range, suggesting the market is pricing in minimal H2 recovery cushion — any evidence of service margin inflection in Q2 could be a meaningful positive catalyst.
Key Takeaway: OTIS has significantly underperformed since Q1 earnings, driven by multiple compression rather than estimate cuts — the stock is down ~7.6% vs. XLI +4.5% and SPY +5.2%, reflecting sentiment deterioration and macro-driven industrial rotation away from service-heavy names with near-term margin headwinds.
OTIS vs. XLI (Industrials ETF) vs. S&P 500 — Indexed to 100 at Q1 2026 Earnings (April 22, 2026). Source: Yahoo Finance.
Since the Q1 2026 earnings print on April 22, 2026, OTIS has declined from $77.88 to $71.95 (as of July 21, 2026), a loss of approximately -7.6% on an absolute basis. Over the same period, the XLI Industrials ETF gained +4.5% and the S&P 500 (SPY) gained +5.2%, resulting in a cumulative underperformance of approximately ~12–13 percentage points vs. both benchmarks. The underperformance is not driven by estimate cuts — FY 2026 EPS consensus has barely moved since the Q1 print — but rather by multiple compression and sentiment deterioration as investors rotated toward higher-growth industrials (data center HVAC, automation) and away from service-heavy names with near-term margin headwinds. The stock’s forward P/E in the low-20s sits below its historical average and well below the peer group, suggesting the market is pricing in continued execution risk rather than the H2 recovery management has guided. The May 7 debt issuance ($700M in 4.488% notes due 2029) was a minor event with no material stock impact. The stock’s current valuation represents an attractive entry point if Q2 service margins confirm the sequential recovery trajectory.
Key Takeaway: The most important development since Q1 earnings is the ongoing Middle East conflict, which management assumed would end in Q2 — if it has not, the company faces a $5–10M per quarter profit headwind that could pressure Q2 results and force a guidance revision for H2.
Key Takeaway: Peer commentary from the last 60 days is broadly constructive for OTIS’s Q2 setup: building services demand remains robust, Middle East headwinds are real but manageable and assumed to ease, and China commercial construction is showing early signs of stabilization. The most relevant read-throughs are from Trane Technologies (TT), Johnson Controls (JCI), Carrier (CARR), Honeywell (HON), and Emerson (EMR) — all of which reported Q1 or Q2 2026 results in the last 60 days and provided commentary directly relevant to OTIS’s Q2 2026 reporting period.
Note on peer selection: Only commentary from peers’ Q1/Q2 2026 earnings calls and post-Q1 investor events (April–July 2026) is included below, as these reflect conditions during OTIS’s Q2 2026 reporting period (April–June 2026). Prior-quarter results commentary has been excluded.
Relevance to OTIS: High. TT is a leading building services and HVAC peer with significant overlap in commercial construction end markets, service business dynamics, and Middle East exposure.
Relevance to OTIS: High. JCI is the most direct peer in building services, with a large service business (~1/3 of revenue), significant overlap in commercial construction end markets, and Middle East exposure. JCI’s Q2 2026 covers the same calendar period as OTIS’s Q2 2026.
Relevance to OTIS: Medium-High. CARR is a building services and HVAC peer with significant commercial construction exposure, aftermarket/service business, and Middle East presence.
Relevance to OTIS: Medium. HON’s Building Automation segment is a relevant peer for commercial building services demand trends, though HON’s primary exposure is to HVAC controls and automation rather than elevator/escalator maintenance.
Relevance to OTIS: Medium. EMR’s primary exposure is to process automation and industrial automation rather than building services, but its Middle East commentary and China outlook are directly relevant to OTIS’s Q2 setup.
Relevance to OTIS: Medium. JCI’s investor day provided forward-looking commentary on building services demand trends and data center growth that is relevant to OTIS’s long-term service and modernization opportunity.
Theme | Peer Signal | Direction for OTIS | Key Peer |
Building Services Demand | Services growing double digits; record backlogs; strong order momentum | Positive | TT, JCI, CARR |
Middle East Conflict (Q2 2026) | Conflict persisted through Q2; JCI saw 1/3 of ME business impacted; HON guided 1% revenue impact in Q2; EMR at <50% field service capacity in March | Negative | JCI, HON, EMR, TT |
China Construction | JCI believes China has ‘bottomed out’; CARR seeing commercial HVAC stabilize; EMR China down mid-single digits (chemical-specific) | Neutral / Slightly Positive | JCI, CARR |
Pricing Power | HON pricing above 3%; CARR adding 2 pts of pricing globally; TT pricing ~2 pts; all successfully passing through cost increases | Positive | HON, CARR, TT |
Americas Commercial Construction | TT Americas CHVAC bookings at all-time high (+40% YoY); JCI Americas orders +40%; data centers, healthcare, education driving demand | Positive | TT, JCI |
MRO / Repair Resilience | EMR MRO 65% of sales; resilient in North America; no negative trends globally ex-Middle East | Positive | EMR |
Data Center Demand | CARR data center orders +500%; JCI backlog at record $20B; TT applied bookings +160%; all seeing exceptional data center demand | Positive (long-term) | CARR, JCI, TT |
Bottom Line: The peer read-through is broadly constructive for OTIS’s service and modernization business, but the Middle East commentary from JCI, HON, EMR, and TT collectively suggests the conflict did NOT end in Q2 as OTIS assumed — the most important negative read-through heading into the print. If OTIS confirms the $5–10M per quarter headwind persisted through Q2, it may need to revise its H2 recovery assumptions.
Key Takeaway: No open-market buys or discretionary sells from senior executives since Q1 earnings. The only notable transaction is a routine open-market sale by the President of Otis EMEA (Thibault Lefebure) on May 7 — not on a 10b5-1 plan, but modest in size. Director deferred stock unit awards are routine compensation and carry no signal.
Name | Title | Transaction Type | Shares / Value | Date | Note |
Lefebure, Thibault Pierre Marie | President, Otis EMEA | Open Market Sale | 1,628 shares | May 7, 2026 | Discretionary sale; not flagged as 10b5-1 plan; modest size relative to remaining holdings of 4,008 shares; no clear signal |
Armas, Joseph Jay | President, Otis Americas | Tax Withholding (Code F) | 421 shares | June 2, 2026 | Shares withheld for tax obligation on vesting; not a discretionary sale; no signal |
Bartlett, Thomas A. | Director | Deferred Stock Unit Award (Code A) | 2,716 DSUs | May 27, 2026 | Routine annual director compensation award; no signal |
Black, Jeffrey Harry | Director | Deferred Stock Unit Award (Code A) | 2,800 DSUs | May 27, 2026 | Routine annual director compensation award; no signal |
Brannon, Jill | Director | Deferred Stock Unit Award (Code A) | 4,527 DSUs | May 27, 2026 | Routine annual director compensation award; no signal |
Connors, Nelda J. | Director | Deferred Stock Unit Award (Code A) | 2,716 DSUs | May 27, 2026 | Routine annual director compensation award; no signal |
Hannan, Kathy Hopinkah | Director | Deferred Stock Unit Award (Code A) | 2,758 DSUs | May 27, 2026 | Routine annual director compensation award; no signal |
Kearney, Christopher J. | Director | Deferred Stock Unit Award (Code A) | 2,591 DSUs | May 27, 2026 | Routine annual director compensation award; no signal |
Preston, Margaret M.V. | Director | Deferred Stock Unit Award (Code A) | 4,597 DSUs | May 27, 2026 | Routine annual director compensation award; no signal |
Stewart, Shelley JR | Director | Deferred Stock Unit Award (Code A) | 2,591 DSUs | May 27, 2026 | Routine annual director compensation award; no signal |
Walker, John H. | Director | Deferred Stock Unit Award (Code A) | 4,806 DSUs | May 27, 2026 | Routine annual director compensation award; no signal |
Source: SEC Form 4 filings via Insider Transaction Data. Period covered: April 22, 2026 – July 21, 2026.
Assessment: Insider activity since Q1 earnings is unremarkable. The only open-market sale is from the President of Otis EMEA (1,628 shares on May 7), which is modest in size and not on a 10b5-1 plan, but also not large enough to be a meaningful negative signal. The absence of any open-market buys from senior management (CEO, CFO, or segment presidents) is notable given the stock’s ~7.6% decline since Q1 earnings, but is not unusual for a company in a quiet period ahead of earnings. No clustered buys or unusual sale patterns to flag.